Dashboard
Manage Tickers

TTOO T2 Biosystems, Inc.

Nasdaq t2biosystems.com


$ 0.01 (71.43 %)    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 598.50 $ -4.01 (-0.67 %)
DIA $ 463.08 $ 2.03 (0.44 %)
SPY $ 662.74 $ -0.81 (-0.12 %)
TLT $ 90.69 $ 0.29 (0.32 %)
GLD $ 382.95 $ 2.70 (0.71 %)
$ 0.012
-- x --
-- x --
-- - --
$ 0.00 - $ 1.86
5,405
na
2.82M
$ -1.03
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-14-2024 09-30-2024 10-Q
2 08-08-2024 06-30-2024 10-Q
3 05-06-2024 03-31-2024 10-Q
4 04-01-2024 12-31-2023 10-K
5 11-14-2023 09-30-2023 10-Q
6 08-08-2023 06-30-2023 10-Q
7 05-22-2023 03-31-2023 10-Q
8 03-31-2023 12-31-2022 10-K
9 11-14-2022 09-30-2022 10-Q
10 08-15-2022 06-30-2022 10-Q
11 05-12-2022 03-31-2022 10-Q
12 03-23-2022 12-31-2021 10-K
13 11-04-2021 09-30-2021 10-Q
14 08-09-2021 06-30-2021 10-Q
15 05-13-2021 03-31-2021 10-Q
16 03-31-2021 12-31-2020 10-K
17 11-05-2020 09-30-2020 10-Q
18 08-12-2020 06-30-2020 10-Q
19 05-11-2020 03-31-2020 10-Q
20 03-16-2020 12-31-2019 10-K
21 11-18-2019 09-30-2019 10-Q
22 08-02-2019 06-30-2019 10-Q
23 05-10-2019 03-31-2019 10-Q
24 03-14-2019 12-31-2018 10-K
25 11-01-2018 09-30-2018 10-Q
26 08-02-2018 06-30-2018 10-Q
27 05-08-2018 03-31-2018 10-Q
28 03-19-2018 12-31-2017 10-K
29 11-03-2017 09-30-2017 10-Q
30 08-04-2017 06-30-2017 10-Q
31 05-08-2017 03-31-2017 10-Q
32 03-15-2017 12-31-2016 10-K
33 11-08-2016 09-30-2016 10-Q
34 08-08-2016 06-30-2016 10-Q
35 05-09-2016 03-31-2016 10-Q
36 03-09-2016 12-31-2015 10-K
37 11-04-2015 09-30-2015 10-Q
38 08-05-2015 06-30-2015 10-Q
39 05-06-2015 03-31-2015 10-Q
40 03-04-2015 12-31-2014 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

12-health-care-stocks-moving-in-tuesdays-pre-market-session
12 Health Care Stocks Moving In Tuesday's ...
02/11/2025 21:06:07

t2-biosystems-announces-prelim-financial-results-sees-q4-revenues-of-23m-and-2024-revenues-of-83m
T2 Biosystems Announces Prelim. Financial ...
01/07/2025 14:04:42

t2-biosystems-sells-four-t2dx-instruments-to-existing-european-distributor-amount-not-disclosed
T2 Biosystems Sells Four T2Dx Instruments ...
12/18/2024 14:04:09

The multiple instrument sale demonstrates commercial expansion to enable increased utilization of the T2Bacteria® Panel, the T2...

t2-biosystems-announced-that-its-multi-year-capital-equipment-supplier-agreement-with-vizient-has-been-extended-through-march-31-2026
T2 Biosystems Announced That Its Multi-Yea...
12/16/2024 14:03:00

Core News & Articles
T2 Biosystems To License Proprietary Techn...
12/09/2024 14:06:55

t2-biosystems-shares-are-trading-lower-after-the-company-reported-worse-than-expected-q3-revenue-results
T2 Biosystems shares are trading lower aft...
11/15/2024 16:51:35

t2-biosystems-expects-q4-2024-sepsis-product-revenue-to-be-25m-to-35m
T2 Biosystems Expects Q4 2024 sepsis produ...
11/14/2024 21:15:23

T2 Biosystems (NASDAQ:TTOO) .

t2-biosystems-q3-2024-gaap-eps-057-beats-064-estimate-sales-1985m-miss-2800m-estimate
T2 Biosystems Q3 2024 GAAP EPS $(0.57) Bea...
11/14/2024 21:00:28

T2 Biosystems (NASDAQ:TTOO) reported quarterly losses of $(0.57) per share which beat the analyst consensus estimate of $(0.64)...

earnings-scheduled-for-november-14-2024
Earnings Scheduled For November 14, 2024
11/14/2024 08:32:28

insights-ahead-t2-biosystemss-quarterly-earnings
Insights Ahead: T2 Biosystems's Quarterly ...
11/13/2024 16:01:58

t2-biosystems-and-prxcision-announce-co-marketing-collaboration-to-offer-rapid-direct-from-blood-diagnostics-and-ai-powered-decision-support-platform-to-address-bloodstream-infections-and-combat-antibiotic-resistance-crisis
T2 Biosystems And Prxcision Announce Co-Ma...
10/08/2024 13:06:56

t2-biosystems-sees-q4-revenue-25m-35m-vs-37m-est
T2 Biosystems Sees Q4 Revenue $2.5M-$3.5M ...
10/07/2024 13:13:30

t2-biosystems-sees-preliminary-q3-revenue-20m-vs-28m-est
T2 Biosystems Sees Preliminary Q3 Revenue ...
10/07/2024 13:11:02

Core News & Articles
T2 Biosystems Enters Multi-Year Exclusive ...
10/07/2024 13:06:02

t2-biosystems-highlights-new-article-published-in-the-lancet-titled-changing-the-culture-of-blood-culture
T2 Biosystems Highlights New Article Publi...
09/23/2024 13:12:03

T2 Biosystems, Inc. (NASDAQ:TTOO) (the "Company"), a leader in the rapid detection of sepsis-causing pathogens and anti...

t2-biosystems-successfully-defends-patent-for-direct-from-whole-blood-pathogen-detection-method-in-european-union-maintaining-strong-ip-position
T2 Biosystems Successfully Defends Patent ...
09/20/2024 13:03:55

t2-biosystems-receives-fda-clearance-to-market-t2candida-panel-for-pediatric-patients-the-only-test-detecting-sepsis-causing-candida-species-directly-from-blood-in-3-5-hours-without-blood-culture-panel-detects-five-candida-species-responsible-for-95-of-us-bloodstream-infections
T2 Biosystems Receives FDA Clearance To Ma...
09/16/2024 13:01:59

t2-biosystems-provides-updates-on-new-product-development-pipeline-progress
T2 Biosystems Provides Updates On New Prod...
09/09/2024 13:10:26

Finalizing a 510(k) premarket notification application for the T2Resistance® Panel planned to be filed with the U.S. Food and D...

t2-biosystems--gets-australian-approval-for-its-t2candida-in-vitro-diagnostic-for-the-detection-of-sepsis-causing-fungal-pathogens-from-whole-blood
T2 Biosystems Gets Australian Approval Fo...
08/19/2024 16:16:11

https://www.tga.gov.au/resources/artg/459987

t2-biosystems-shares-are-trading-higher-after-the-company-reported-better-than-expected-q2-eps-results-also-canaccord-genuity-maintained-a-hold-rating-on-the-stock-and-raised-its-price-target-from-3-to-5
T2 Biosystems shares are trading higher af...
07/30/2024 12:01:28

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION